z-logo
open-access-imgOpen Access
Tier 3 specialist weight management service and pre‐bariatric multicomponent weight management programmes for adults with obesity living in the UK: A systematic review
Author(s) -
Alkharaiji Mohammed,
Anyanwagu Uchenna,
Donnelly Richard,
Idris Iskandar
Publication year - 2019
Publication title -
endocrinology, diabetes and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2398-9238
DOI - 10.1002/edm2.42
Subject(s) - cinahl , medicine , weight management , weight loss , obesity , waist , psycinfo , medline , management of obesity , systematic review , inclusion (mineral) , gerontology , physical therapy , family medicine , psychological intervention , nursing , psychology , social psychology , political science , law
Summary Background NHS England has recommended a multidisciplinary weight management services (MWMS—Tier 3 services) for patients requiring specialized management of obesity, including bariatric surgery, but clinical and measurable health‐related outcomes from these services remains fragmented. We therefore undertook a systematic review to explore the evidence base of effect on body weight loss and comorbidities outcomes of Tier 3 or UK pre‐bariatric MWMPs. Methods AMED, CINAHL, EMBASE, HMIC, MEDLINE, PsycINFO, PubMed, HDAS search and Google Scholar were searched from January 2000 to September 2017 in a free‐text fashion and crossed‐references of included studies to identify potential illegibility. Inclusion criteria were as follows: (a) published Tier 3 original study abstracts/articles; (b) intervention studies with before and after data; (c) studies that included any sort of MWMPs conducted on British residents with obesity; and (d) studies included T2DM measurements in a MWMPs. Results In total, 19 studies met the inclusion criteria. The total number of participants analysed was N = 11,735. Baseline accumulative average BMI was calculated at 42.54 kg/m 2 , weight 117.88 kg and waist circumference 126.9 cm. And at 6 months, 40.73 kg/m 2 , 112.17 kg and 120.3 cm, respectively. Secondary outcome variables were as improved with reduction in HbA1c, fasting blood sugars, insulin usage and blood pressure. Physical activity increased at 3 months then declined after 6 months with no significant changes in cholesterol levels. Conclusion Tier 3 and MWMPs have a short to mid‐ranged positive effect on obese patients (BMI ≥30 kg/m 2 ) living in the UK regarding accumulated reduction in weight, glycaemic control, blood pressure and with subtle improvements in physical activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here